Nippon India Pharma Fund
Emcure Pharmaceuticals L · NSE
7,46,337 sh · ₹146.29 Cr
Nippon India Multi Cap Fund
0.6% of their portfolio
₹336.56 Cr
17,17,080 sh
Aditya Birla Sun Life ELSS Tax Saver Fund
1.7% of their portfolio
₹247.85 Cr
13,49,941 sh
SBI Flexicap Fund
97.0% of their portfolio
₹221.29 Cr
11,28,993 sh
Nippon India Pharma Fund
1.6% of their portfolio
₹146.29 Cr
7,46,337 sh
Nippon India ELSS Tax Saver Fund
0.7% of their portfolio
₹103.79 Cr
6,11,992 sh
Aditya Birla Sun Life Multi-Cap Fund
1.1% of their portfolio
₹80.74 Cr
4,39,742 sh
Aditya Birla Sun Life Small Cap Fund
1.2% of their portfolio
₹66.36 Cr
3,61,420 sh
Aditya Birla Sun Life Large & Mid Cap Fund
0.9% of their portfolio
₹50.59 Cr
2,75,555 sh
Vineeta Adityakumar Ruia
Investor
₹47.50 Cr
2,61,420 sh
Aditya Birla Sun Life Quant Fund
Fund
₹47.50 Cr
2,61,420 sh
Aditya Birla Sun Life Pharma & Healthcare Fund
3.2% of their portfolio
₹32.64 Cr
1,77,757 sh
HDFC Standard Life Insurnace
Investor
₹28.70 Cr
1,57,949 sh
FIIs raised their stake +1.5pp QoQ
Jun 2026 quarter
Ownership by quarter
Promoter
— 0.0pp
Nippon India Pharma Fund
Emcure Pharmaceuticals L · NSE
7,46,337 sh · ₹146.29 Cr
ICICI Prudential Nifty Smallcap 250 ETF
Emcure Pharmaceuticals L · NSE
142 sh · ₹2.78 L
SBI Nifty 500 Index Fund
Emcure Pharmaceuticals L · NSE
1,343 sh · ₹26.32 L
Groww Mutual Fund (scheme NI)
Emcure Pharmaceuticals L · NSE
609 sh · ₹11.94 L
Groww Mutual Fund (scheme XC)
Emcure Pharmaceuticals L · NSE
259 sh · ₹5.08 L
HDFC Mutual Fund (scheme HDFCGR)
Emcure Pharmaceuticals L · NSE
81,119 sh · ₹15.90 Cr
Groww Mutual Fund (scheme NS)
Emcure Pharmaceuticals L · NSE
2,161 sh · ₹42.36 L
Nippon India Multi Cap Fund
Emcure Pharmaceuticals L · NSE
17,17,080 sh · ₹336.56 Cr
ICICI Prudential Nifty 500 Index Fund
Emcure Pharmaceuticals L · NSE
166 sh · ₹3.25 L
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
27 announcements on record for this company.
Promoter holding by quarter: Jun 2025 77.9%, Sep 2025 77.9%, Dec 2025 77.9%, Mar 2026 77.9%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— −0.2pp
FII holding by quarter: Jun 2025 2.9%, Sep 2025 3.3%, Dec 2025 3.6%, Mar 2026 3.4%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— 0.0pp
DII holding by quarter: Jun 2025 2.8%, Sep 2025 4.4%, Dec 2025 6.1%, Mar 2026 6.1%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— +0.1pp
MF holding by quarter: Jun 2025 2.3%, Sep 2025 3.6%, Dec 2025 4.8%, Mar 2026 4.9%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
Nippon India Nifty Smallcap 250 Index Fund
Emcure Pharmaceuticals L · NSE
54,167 sh · ₹10.62 Cr
Ownership by quarter
Promoter
— 0.0pp
Promoter holding by quarter: Jun 2025 77.9%, Sep 2025 77.9%, Dec 2025 77.9%, Mar 2026 77.9%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— −0.2pp
FII holding by quarter: Jun 2025 2.9%, Sep 2025 3.3%, Dec 2025 3.6%, Mar 2026 3.4%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— 0.0pp
DII holding by quarter: Jun 2025 2.8%, Sep 2025 4.4%, Dec 2025 6.1%, Mar 2026 6.1%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— +0.1pp
MF holding by quarter: Jun 2025 2.3%, Sep 2025 3.6%, Dec 2025 4.8%, Mar 2026 4.9%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
27 announcements on record for this company.